First Horizon Advisors Inc. Has $84,000 Holdings in Stevanato Group S.p.A. (NYSE:STVN)

First Horizon Advisors Inc. decreased its stake in Stevanato Group S.p.A. (NYSE:STVN) by 19.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,205 shares of the company’s stock after selling 1,037 shares during the quarter. First Horizon Advisors Inc.’s holdings in Stevanato Group were worth $84,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Thrivent Financial for Lutherans acquired a new stake in Stevanato Group during the 2nd quarter valued at $30,477,000. Pembroke Management LTD raised its holdings in shares of Stevanato Group by 143.7% in the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock valued at $21,023,000 after buying an additional 619,747 shares during the last quarter. Tri Locum Partners LP bought a new position in shares of Stevanato Group in the second quarter valued at about $10,370,000. Thornburg Investment Management Inc. lifted its position in Stevanato Group by 279.1% during the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock worth $13,690,000 after buying an additional 549,378 shares in the last quarter. Finally, Conestoga Capital Advisors LLC grew its holdings in Stevanato Group by 7.3% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 7,275,823 shares of the company’s stock worth $133,439,000 after acquiring an additional 496,930 shares during the last quarter.

Wall Street Analyst Weigh In

Separately, Citigroup dropped their price objective on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

Stevanato Group Trading Up 0.2 %

STVN opened at €19.65 ($20.68) on Monday. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($17.43) and a fifty-two week high of €34.73 ($36.56). The company has a market cap of $5.81 billion, a price-to-earnings ratio of 41.81, a price-to-earnings-growth ratio of 8.83 and a beta of 0.58. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The firm has a 50 day simple moving average of €19.44 and a 200 day simple moving average of €19.65.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company had revenue of €277.90 million for the quarter, compared to analyst estimates of €274.36 million. During the same period last year, the firm earned $0.16 earnings per share. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. On average, sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.